This company has been marked as potentially delisted and may not be actively trading. Medicis Pharmaceutical (MRX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Marex Group PLC - MRXAugust 27 at 10:00 AM | prnewswire.comMarex Group (MRX) Faces Investor Scrutiny Amid Short Seller Accusations – Hagens BermanAugust 25, 2025 | globenewswire.comINVESTOR ALERT: Investigation of Marex Group plc (MRX) Announced by Holzer & Holzer, LLCAugust 25, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Marex Group PLC - MRXAugust 25, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Marex Group PLC - MRXAugust 22, 2025 | prnewswire.comMRX Investors Have Opportunity to Join Marex Group plc Fraud Investigation with the Schall Law FirmAugust 21, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Marex Group PLC - MRXAugust 21, 2025 | globenewswire.comMarex Group (MRX) Faces Investor Scrutiny Amid Short Seller Accusations – Hagens BermanAugust 19, 2025 | globenewswire.comMarex Group (MRX) Faces Investor Scrutiny Amid Short Seller Accusations – Hagens BermanAugust 15, 2025 | globenewswire.comMarex Group plc (MRX) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comMarex Group plc announces second quarter 2025 resultsAugust 13, 2025 | globenewswire.comMarex Group (MRX) Faces Investor Scrutiny Amid Short Seller Accusations – Hagens BermanAugust 12, 2025 | globenewswire.comMarex Group (MRX) Faces Investor Scrutiny Amid Short Seller Accusations – Hagens BermanAugust 8, 2025 | globenewswire.comSecurities Fraud Investigation Into Marex Group plc (MRX) Announced – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law FirmAugust 8, 2025 | businesswire.comRosen Law Firm Encourages Marex Group plc Investors to Inquire About Securities Class Action Investigation – MRXAugust 8, 2025 | businesswire.comSecurities Fraud Investigation Into Marex Group plc (MRX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzAugust 7, 2025 | businesswire.comMarex Group (MRX) Faces Investor Scrutiny Amid Short Seller Accusations - Hagens BermanAugust 7, 2025 | prnewswire.comMarex Group (MRX) Faces Investor Scrutiny Amid Short Seller Accusations – Hagens BermanAugust 6, 2025 | globenewswire.comJohnson Fistel Investigates Marex Group Following Damaging Short Seller AllegationsAugust 6, 2025 | businesswire.comINVESTOR ALERT: Investigation of Marex Group plc (MRX) Announced by Holzer & Holzer, LLCAugust 5, 2025 | globenewswire.comMarex Group plc issues statement regarding NINGI Research reportAugust 5, 2025 | globenewswire.comMarex Group ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover LossesAugust 5, 2025 | globenewswire.comUK's Close Brothers to sell Winterflood to Marex for $140 millionJuly 25, 2025 | reuters.comMarex Group plc to acquire UK equity market maker Winterflood SecuritiesJuly 25, 2025 | globenewswire.comMarex Group plc to Announce Second Quarter 2025 Results on August 13, 2025July 14, 2025 | globenewswire.comMarex completes acquisition of FX specialist Hamilton Court GroupJuly 1, 2025 | globenewswire.comMarex Group plc added to membership of Russell 3000® IndexJune 30, 2025 | globenewswire.comMarex Group plc to Participate in Upcoming Piper Sandler Global Exchange & Trading ConferenceJune 2, 2025 | globenewswire.comMarex Group plc (MRX) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comMarex announces departure of Roger Nagioff from the Group BoardMay 15, 2025 | globenewswire.comMarex Group plc announces strong results for first quarter of 2025May 15, 2025 | globenewswire.comMarex Group plc Announces Pricing of U.S.$500 Million Senior Notes OfferingMay 2, 2025 | globenewswire.comFitch updates Marex's outlook to positive due to strong earnings and diversification of franchiseApril 30, 2025 | globenewswire.comMarex Group Plc to Announce First Quarter 2025 Earnings on May 15, 2025April 24, 2025 | globenewswire.comMarex Group plc Announces Pricing of the Public OfferingApril 17, 2025 | globenewswire.comMarex Group plc Announces Launch of a Public OfferingApril 14, 2025 | globenewswire.comMarex Group plc provides preliminary Q1 results range and hosts Investor Day in New YorkApril 2, 2025 | globenewswire.comMarex Group plc Provides Details for Upcoming Investor Day on April 2, 2025March 24, 2025 | globenewswire.comMarex Group plc announces record fourth quarter and full year 2024 resultsMarch 6, 2025 | globenewswire.comMarex Group plc to Announce Fourth Quarter and Full Year 2024 Results on March 6, 2025 with an Investor Day on April 2, 2025February 17, 2025 | globenewswire.comMicuRx Pharmaceuticals: FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM InfectionsFebruary 2, 2025 | finanznachrichten.deMarex Group plc Announces Third Quarter 2024 ResultsNovember 7, 2024 | globenewswire.comMarex Group plc Announces Pricing of the Public OfferingOctober 24, 2024 | globenewswire.comMarex Group Plc to Announce Third Quarter 2024 Earnings on November 7, 2024October 22, 2024 | globenewswire.comMarex Group plc Announces Launch of a Public OfferingOctober 21, 2024 | globenewswire.comIPO Stock Of The Week: Financial Firm Marex Nears Buy Point After 43% RallyOctober 18, 2024 | investors.comMarex Agrees Terms to Acquire UK FX Specialist Hamilton Court GroupOctober 9, 2024 | globenewswire.comMarex Expands in the Middle East with the Acquisition of Aarna CapitalOctober 2, 2024 | globenewswire.comMarex Acquires Biofuels Company DropetOctober 1, 2024 | globenewswire.comKey Carbon & Marex Group Announce Carbon Financing and InvestmentSeptember 26, 2024 | globenewswire.com Get Medicis Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for MRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRX Media Mentions By Week MRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRX News Sentiment▼0.001.18▲Average Finance News Sentiment MRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRX Articles This Week▼41▲MRX Articles Average Week Get the Latest News and Ratings for MRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Medicis Pharmaceutical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CBOE News Today SEIC News Today HST News Today AIZ News Today FRHC News Today BXP News Today KNSL News Today AGNC News Today GLXY News Today SSB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicis Pharmaceutical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicis Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access